Concepedia

Sukyung Woo

SW

Statistics

Publications

36

Citations

2.4K

H-Index

26

Active since

2006

Affiliations

University of Oklahoma Health Sciences Center(Current)

National Cancer Institute

University at Buffalo, State University of New York

Center for Cancer Research

National Institutes of Health

Sukyung Woo is an author at University of Oklahoma Health Sciences Center specializing in pharmacology, cancer pharmacology, and medicine.

ORCID

Publications per year

2006–2024

36

Publications

36

Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions

Lucia Vojtech, Sukyung Woo, Sean M. Hughes et al. · Nucleic Acids Research · 2014 · 581 citations · Full text

, , +10

A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid Tumors

Arun Rajan, Corey A. Carter, Ronan J. Kelly et al. · Clinical Cancer Research · 2012 · 166 citations · Full text

, , +17

Phase II Trial of Bevacizumab, Thalidomide, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer

Yang‐Min Ning, James L. Gulley, Philip M. Arlen et al. · Journal of Clinical Oncology · 2010 · 145 citations · Full text

, , +17

Population pharmacokinetic analysis of sorafenib in patients with solid tumours

Lokesh Jain, Sukyung Woo, Erin R. Gardner et al. · British Journal of Clinical Pharmacology · 2011 · 144 citations · Full text

, , +14

Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia

Cody J. Peer, Tristan M. Sissung, AeRang Kim et al. · Clinical Cancer Research · 2012 · 130 citations · Full text

, , +15

1–5 of 36